Clinical Trial Update: XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating XELOX (capecitabine plus oxaliplatin) in combination with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Tyvyt (Sintilimab)
• Xeloda (capecitabine)

Snippet

Sponsor: West China Hospital | Conditions: Gastric (Stomach) Cancer | Phase 1, Phase 2 | Status: RECRUITING